SUMMARY Quantitative thyroid scanning using low doses of 99mTc sodium pertechnetate (1 85-3.7 MBq) was performed in 38 cases of congenital hypothyroidism. Of these 38 cases, 29 were scanned at 14 + 6 days old, and 9 at 1 year old. The scans show the full range of gland anatomy from athyreotic to normal. All morphologically normal scans had grossly increased uptakes of 99mTc. The incidence of the various thyroid anatomies was different in each age group. The average radiation dose to the thyroid was 2 e 29 mGy, with at least 70 % of patients receiving a dose of 3*0 mGy or less. Such low doses of 99mTc should allow further scanning in later life. Neonatal thyroid scanning reveals the aetiology of congenital hypothyroidism and enables the clinician to assess the short-and long-term needs of the child. 
Untreated congenital hypothyroidism (CHT) causes mental handicap and probably infants with CHT comprise the largest remaining group for whom specific and effective treatment is available. Screening programmes for CHT were started in 1974 and now exist in over 70 centres throughout the world.' 2 They are of considerable value; not only do they improve the quality of life for the affected infant, but they also save money, for the country is no longer facedwith the maintenance ofa retarded chiild.2
Although it has been recommended that thyroid scanning should be included in screening programmes, Fisher' reported that only 30 % of infants with CHT have received 99mTc scans in the USA, and there is no information on how long after birth such scans were performed. Connolly 10 19 Because the start of the scanning programme was delayed some neonates were not scanned until 1 year old, but the procedure was identical except that a small increase in the dose of 99mTc from 1 .9-3.7 to 3.7-5.6 MBq was found to be necessary. In all infants hormone replacement therapy was changed from thyroxine to triiodothyronine 4 weeks -: : : : : : : : : : : : : . . . . : : : : ' -. : . ' ' f . . . . . : : : 13 Results During the 24-month period from July 1979, about 150 000 neonates were screened of whom 38 had raised TSH levels. Of these 38 cases, 9 had been detected before the start of the scanning programme and were subsequently scanned at 1 year of age. These cases are presented separately in Table 2 . The remaining 29 neonates were scanned within 24-48 hours of the confirmed raised TSH level. The average age of the neonates at scanning was 14-3 ± 6.1 days. 6 However, these results differ greatly from those reported by Fisher' and from the results observed in our study for 1-year-old infants. Fig. 2 shows the distribution of absorbed doses to the thyroid gland in the 29 neonates scanned. The average radiation dose to the thyroid was 2.36 mGy (236 mR) with more than 70% receiving a dose of 3 -0 mGy (300 mR) or less. The dose received by a normal thyroid is 3 4 mGy (340 mR), shown by a dotted line.7 14 The whole-body dose in these neonates was about 0.14 mGy (14 mR).'4
Discussion
The results of the scans showed the full spectrum of possible gland anatomies ranging from athyreotic 18 The low doses used should allow further scanning assessments in later life. This could be especially useful in transient cases and in assessing the development or possible involution of gland function. This is one aspect of CHT for which little information is available.
Thus, dosimetrically, neonatal thyroid scanning can be a fairly safe procedure. However, how necessary and how useful is a thyroid scan? Diagnosis can be confirmed biochemically and there is the reasonable argument that a thyroid scan merely confirms the biochemical finding and imposes a radiation burden, albeit a small one, on the human body during one of its most radiosensitive phases. In reply to this argument it must be said that in many of the neonates scanned no clinical features of CHT were evident5 and clinicians were often less than fully convinced of the biochemical diagnosis unti' confronted with a positive scan finding. Furthermore, definitive proof of a thyroid disorder, as provided by scanning, permits the clinician to proceed with the treatment with confidence, and also allows him better to assess the short and long-term needs of the infant.
